A new somatic mutation in the coding region of Kirsten rat sarcoma viral oncogene homolog gene (KRAS), G48A, has been identified in a patient with non-small cell lung cancer (NSCLC). No other mutations were found by screening several genes known to be mutated in NSCLC. The patient responded to first-line therapy and is still under maintenance treatment 18 months after diagnosis. Normal and cancer cells were engineered to express the KRAS(G48A) mutation. KRAS(G48A) overexpression did not change the growth or the response to treatment compared with KRAS(wild type)-expressing cells. Analysis of the structure of the KRAS(G48A) mutant predicted altered interactions with other proteins. Analysis of KRAS binding to B-Raf proto-oncogene, serine/threonine kinase showed that the KRAS(G48A) mutant behaves more like a wild-type than a classical KRAS(G12) mutant. In conclusion, this new mutation in the coding region of KRAS, found in NSCLC, does not induce phenotypic changes similar to those induced by G12 mutants but presumably affects KRAS binding to proteins other than B-Raf proto-oncogene, serine/threonine kinase.

G48A, a new KRAS mutation found in lung adenocarcinoma / Marabese, Mirko; Caiola, Elisa; Garassino, Marina C.; Rastelli, Giulio; Settanni, Giulio; Brugnara, Sonia; Broggini, Massimo; Ganzinelli, Monica. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - STAMPA. - 11:7(2016), pp. 1170-1175. [10.1016/j.jtho.2016.03.013]

G48A, a new KRAS mutation found in lung adenocarcinoma

RASTELLI, Giulio;
2016

Abstract

A new somatic mutation in the coding region of Kirsten rat sarcoma viral oncogene homolog gene (KRAS), G48A, has been identified in a patient with non-small cell lung cancer (NSCLC). No other mutations were found by screening several genes known to be mutated in NSCLC. The patient responded to first-line therapy and is still under maintenance treatment 18 months after diagnosis. Normal and cancer cells were engineered to express the KRAS(G48A) mutation. KRAS(G48A) overexpression did not change the growth or the response to treatment compared with KRAS(wild type)-expressing cells. Analysis of the structure of the KRAS(G48A) mutant predicted altered interactions with other proteins. Analysis of KRAS binding to B-Raf proto-oncogene, serine/threonine kinase showed that the KRAS(G48A) mutant behaves more like a wild-type than a classical KRAS(G12) mutant. In conclusion, this new mutation in the coding region of KRAS, found in NSCLC, does not induce phenotypic changes similar to those induced by G12 mutants but presumably affects KRAS binding to proteins other than B-Raf proto-oncogene, serine/threonine kinase.
2016
4-apr-2016
11
7
1170
1175
G48A, a new KRAS mutation found in lung adenocarcinoma / Marabese, Mirko; Caiola, Elisa; Garassino, Marina C.; Rastelli, Giulio; Settanni, Giulio; Brugnara, Sonia; Broggini, Massimo; Ganzinelli, Monica. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - STAMPA. - 11:7(2016), pp. 1170-1175. [10.1016/j.jtho.2016.03.013]
Marabese, Mirko; Caiola, Elisa; Garassino, Marina C.; Rastelli, Giulio; Settanni, Giulio; Brugnara, Sonia; Broggini, Massimo; Ganzinelli, Monica
File in questo prodotto:
File Dimensione Formato  
G48A_2016.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 1.41 MB
Formato Adobe PDF
1.41 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1116321
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 5
social impact